Home › Lymphoma › District of Columbia › Washington
Lymphoma clinical trials in Washington, DC
23 studies for Lymphoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RecruitingPhase 2
- Maryland Oncology Hematology, Silver Spring · 7 mi away
Collection of Tissue Samples for Cancer Research
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RecruitingPhase 1/2
- Children's National Medical Center, Washington D.C.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecruitingPhase 3
- Research Site, Bethesda · 7 mi away
Sample Collection and Tracking for the Developmental Therapeutics Clinic
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
RecruitingObservational study
- Walter Reed National Military Medical Center, Bethesda · 7 mi away
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
RecruitingPhase 3
- Georgetown University, Washington D.C.
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Medstar Georgetown University Hospital, Washington D.C.
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
RecruitingPhase 2
- Georgetown University (Data Collection Only), Washington D.C.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- MedStar Georgetown University Hospital, Washington D.C.
Vaccine Responses in Patients With B Cell Malignancies
RecruitingPhase 4
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Mosaic Trial for Stem Cell Transplant Recipients
Recruiting
- Georgetown University School of Medicine, Washington D.C.
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- National Institute of Health, Bethesda · 7 mi away
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RecruitingObservational study
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
About Lymphoma
Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.
More about Lymphoma on MedlinePlus
Lymphoma trials in other cities
- Houston, TX34 studies
- Boston, MA33 studies
- New York City, NY33 studies
- Baldwin Park, CA21 studies
- Chicago, IL20 studies
- Durham, NC17 studies
- St. Louis, MO15 studies
- Philadelphia, PA15 studies
- Cleveland, OH14 studies
- Edison, NJ12 studies
- Seattle, WA12 studies
- Atlanta, GA12 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.